Antifungal Drug Susceptibility and Genetic Characterization of Fungi Recovered from COVID-19 Patients
Article
[키워드] Candida parapsilosis
Candida pneumonia
30-Day mortality
A. fumigatus
Analysis
analyzed
Antifungal
antifungal susceptibility
aspergillosis
Aspergillus fumigatus
azole drug
Blood
bloodstream infection
C. albican
Candida
Candida albican
Candida albicans
candidiasis
center
Characteristics
characterization
chromosomal rearrangement
Clinical data
Clinical outcome
Complication
comprehensive analysis
Corticosteroids
COVID-19
COVID-19 patient
COVID-19 patients
COVID-19-associated candidemia
determinant
drug
elevated
fungal
fungi
genotypes
Hospital stay
Hospitalized
Immunosuppression
Infection
initial
intensive care
intrinsic
isolate
isolates
limit
mechanical ventilation
median
molecular
Mortality
New
pandemic
patient cohort
patient population
performed
Pulsed-field gel electrophoresis
recovered
respiratory tract
respiratory viral infection
retrospective
secondary infections
sequence
susceptibility
susceptible
the patient
university
USA
virus
[DOI] 10.3390/jof7070552 PMC 바로가기 [Article Type] Article
[DOI] 10.3390/jof7070552 PMC 바로가기 [Article Type] Article